Area of research
Neurology · Psychiatry and Mental health
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms, and Cerebrovascular and genetic disorders.
A Two-Stage Questionnaire and Actigraphy Screening for Isolated REM Sleep Behavior Disorder in a Multicenter Cohort
Integrating microfluidic and bioprinting technologies: advanced strategies for tissue vascularization
Cognitive impairment and p‐tau217 are high in a vascular patient cohort
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference
Linking peripheral atherosclerosis to blood–brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
Proteomic profiling of intracranial atherosclerotic plaque in the human brain
The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years?
Placental growth factor as a sensitive biomarker for vascular cognitive impairment
Plasma derived extracellular vesicle biomarkers of microglia activation in an experimental stroke model
Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective
PDE5 inhibitor drugs for use in dementia
Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment
Right temporal degeneration and socioemotional semantics: semantic behavioural variant frontotemporal dementia
Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols
Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)
Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease
β-amyloid and tau drive early Alzheimer’s disease decline while glucose hypometabolism drives late decline
An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection
Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3‐EF)
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration
Plasma biomarkers of astrocytic and neuronal dysfunction in early‐ and late‐onset Alzheimer's disease
Preclinical translation of exosomes derived from mesenchymal stem/stromal cells
Altered levels of plasma neuron‐derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury
Increases in a Pro-inflammatory Chemokine, MCP-1, Are Related to Decreases in Memory Over Time